June 26, 2013

The Food and Drug Administration has approved a drug made by Astellas Pharma for treating fungal infections in children.

June 25, 2013

The Food and Drug Administration has given special designation to a drug made by Raptor Pharmaceuticals for a rare metabolic disease.

June 25, 2013

The Food and Drug Administration is allowing the marketing of two new tobacco products under regulations that allow tobacco companies to market products if they can prove they are similar enough to ones already on the market.

June 25, 2013

Canadian regulators have approved a drug for treating a condition that affects up to three-quarters of women and causes excessive bleeding from the uterus.

June 25, 2013

A new article in Men's Health magazine gives tips on how men can find alternatives to seeing their doctors about health problems, and those alternatives include pharmacists.

June 25, 2013

It appears that medication adherence among Americans age 40 years and older ranges from mediocre to worse, according to a new report by a trade group representing independent pharmacies.

June 25, 2013

Drug makers may be allowed to seek approval for a generic version of an eye drug made by Allergan based on lab tests rather than clinical trials, according to published reports.

June 25, 2013

Takeda Pharmaceutical Co. is seeking Food and Drug Administration approval for an experimental treatment for inflammatory bowel disease, the drug maker said.

June 24, 2013

The Consumer Healthcare Products Association board of directors on Friday approved voluntary labeling guidelines for caffeine-containing dietary supplements discussed during the June 18 board meeting.

June 24, 2013

A White House trade policy leader has been appointed as U.S. Trade Representative.

June 24, 2013

The country's largest organization representing retired and elderly people is pushing for education on healthcare reform among Hispanic communities.

June 24, 2013

The Specialty Pharmacy Certification Board has published a handbook containing information about applying for and maintaining specialty pharmacist credentials.

June 24, 2013

Generic drug makers cannot be held liable if patients suffer harmful side effects after taking their drugs, the Supreme Court has ruled in a 5-4 decision.

June 21, 2013

The Food and Drug Administration has approved a contraceptive pill for all women of childbearing potential without a prescription, the agency said.

June 21, 2013

A bill passed by the New York state legislature will require baby boomers visiting healthcare providers to be offered a hepatitis C screening.

June 20, 2013

A bill recently introduced in the House of Representatives would delay competitive bidding under Medicare for medical equipment until some issues are resolved.

June 20, 2013

Under a new law, pharmacists in Indiana will be able to provide an expanded range of immunizations that includes human papillomavirus.

June 19, 2013

The American Medical Association has officially recognized obesity as a disease, which could affect how healthcare professionals approach the issue, the group said at its annual meeting in Chicago.

June 19, 2013

More responsible use of drugs could save the U.S. healthcare system more than $200 billion per year, according to a new study by the research arm of IMS Health.

June 18, 2013

The Food and Drug Administration's Center for Drug Evaluation and Research has collected 84% of the fees it intends to collect this year under a law passed last year to collect user fees from generic drug members, according to a memo sent out to CDER staff Tuesday.

June 18, 2013

Consumer packaged goods companies and retailers that sell their products have managed to stay strong despite economic difficulty, according to a new report.

June 17, 2013

BioScrip will acquire a Cincinnati-based home infusion company for $223 million, BioScrip said Monday.

June 17, 2013

Drug maker Johnson & Johnson plans to spend up to $1 billion to acquire a privately owned company developing a drug for prostate cancer.

June 17, 2013

Perrigo Co. will pay up to $129 million to buy Fera Pharmaceuticals' portfolio of ophthalmic products, Perrigo said.